Cite
Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
MLA
Fortea J., et al. Plasma and CSF Biomarkers for the Diagnosis of Alzheimer’s Disease in Adults with Down Syndrome: A Cross-Sectional Study. Jan. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.RECOLECTA.....e21ef820691511b38102569ae186812a&authtype=sso&custid=ns315887.
APA
Fortea J., Carmona-Iragui M., Benejam B., Fernández S., Videla L., Barroeta I., Alcolea D., Pegueroles J., Muñoz L., Belbin O., de Leon M.J., Maceski A.M., Hirtz C., Clarimón J., Videla S., Delaby C., Lehmann S., Blesa R., & Lleó A. (2018). Plasma and CSF biomarkers for the diagnosis of Alzheimer’s disease in adults with Down syndrome: a cross-sectional study.
Chicago
Fortea J., Carmona-Iragui M., Benejam B., Fernández S., Videla L., Barroeta I., Alcolea D., et al. 2018. “Plasma and CSF Biomarkers for the Diagnosis of Alzheimer’s Disease in Adults with Down Syndrome: A Cross-Sectional Study,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.RECOLECTA.....e21ef820691511b38102569ae186812a&authtype=sso&custid=ns315887.